SEC 13F Intelligence

Greystone Financial Group, LLC / ABT

Greystone Financial Group, LLC’s Abbott Laboratories Position

Does Greystone Financial Group, LLC own Abbott Laboratories (ABT)? Yes — 53.9K shares worth $6M (+1.57% of its 13F portfolio) as of Q1 2026, down from 90.5K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
53.9K
% of Portfolio
+1.57%
Quarters Held
12
currently held

Position History ABT

Reported value by quarter
Q2 ’23: $4MQ2 ’23Q3 ’23: $5MQ4 ’23: $9MQ4 ’23Q1 ’24: $10MQ2 ’24: $10MQ2 ’24Q3 ’24: $11MQ4 ’24: $11MQ4 ’24Q1 ’25: $12MQ2 ’25: $12MQ2 ’25Q3 ’25: $12MQ4 ’25: $11MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202653.9K$6M+1.57%
Q4 202590.5K$11M+1.77%
Q3 202590.8K$12M+1.88%
Q2 202590.7K$12M+2.03%
Q1 202590.5K$12M+2.18%
Q4 2024101.2K$11M+1.99%
Q3 202496.6K$11M+1.97%
Q2 202499.3K$10M+2.02%
Q1 202484.0K$10M+1.91%
Q4 202379.3K$9M+2.02%
Q3 202349.7K$5M+1.20%
Q2 202336.8K$4M+0.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Greystone Financial Group, LLC’s full portfolio or all institutional holders of ABT.